The company is one of a few drugmakers currently developing a vaccine for the illness, which is spreading rapidly through ...

Moderna surged as investors turned eyed potential demand for a vaccine to protect against bird flu after the US reported its ...

Key Takeaways The S&P 500 fell 1.1% on Tuesday, Jan. 7, as U.S. manufacturing data reinvigorated concerns about inflation and ...

Moderna stock was on track to see a weekly gain of 10% as of Wednesday following the first reported bird flu death in the US.

Moderna stock has been volatile this week as the first death in the U.S. connected to bird flu was reported. Here's what you ...

A 13-year-old girl in Canada became so sick with H5N1, or bird flu, in late 2024 that she had to be put on a ventilator.

Shares of vaccine makers including Moderna, Novavax and CureVac rose Tuesday after U.S. health officials confirmed the first ...

The U.S. will rebuild a stockpile of bird flu vaccines for poultry that match the strain of the virus circulating in ...

Moderna’s current price is less than $20 below the psychologically significant $50 price level. Traders often focus on these ...

The CDC says the risk of bird flu to the general public is low, but public health experts say they are worried the virus could mutate and become more transmissible.

Bird flu has severely impacted poultry farms and cattle herds across 16 states, marking the worst outbreak of its kind.

Shares of Moderna (MRNA), one of a few drugmakers currently developing a vaccine for the H5N1 bird flu, were up nearly 10% in early trading ...